MIC
UTHR icon

MU Investments Company’s United Therapeutics UTHR Stock Holding History

MU Investments Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-560
Closed -$64K – 189
2016
Q3 		$64K Sell
560
-500
-47% -$60.1K 0.05% 147
2016
Q2 		$110K Sell
1,060
-700
-40% -$78.1K 0.07% 159
2016
Q1 		$193K Hold
1,760
– – 0.12% 141
2015
Q4 		$283K Sell
1,760
-260
-13% -$37.8K 0.17% 97
2015
Q3 		$277K Sell
2,020
-100
-5% -$16K 0.15% 129
2015
Q2 		$362K Buy
+2,120
New +$381K 0.17% 110

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

MU Investments Company's UTHR Position: Q4 2016 in Review

MU Investments Company sold out of United Therapeutics (UTHR) in Q4 2016, closing a stake of 560 shares — an estimated $64K sold.

MU Investments Company first reported a position in UTHR in Q2 2015 and held it in 6 quarters. The position peaked at $362K in Q2 2015. 406 funds tracked by Wall St. Rank hold UTHR as of Q4 2016.

  • MU Investments Company reported no remaining United Therapeutics position as of Q4 2016 after selling out during the quarter.
  • MU Investments Company sold 560 United Therapeutics shares in Q4 2016, an estimated $64K.
  • MU Investments Company first reported a position in United Therapeutics in Q2 2015 and held it in 6 quarters.
  • MU Investments Company's United Therapeutics position peaked at $362K in Q2 2015.
  • 406 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2016.

Based on MU Investments Company's 13F filing for Q4 2016, filed 17 Jan 2017.